Vascular Mechanisms of Hypertensive Nephropathy
高血压肾病的血管机制
基本信息
- 批准号:10363532
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAlbuminuriaAngiotensin IIAnimal ModelAttentionBehaviorBirdsBlood Pressure MonitorsBlood VesselsChronic Kidney FailureDahl Hypertensive RatsDefectDevelopmentDifferentiation and GrowthEnd stage renal failureEndothelial CellsEventExtracellular MatrixFamilyFibrosisFunctional disorderGelatinase BGeneral PopulationGlomerular Filtration RateHomeostasisHomologous GeneHumanHypertensionHypoxiaImpairmentInflammationInflammatoryInjuryInvestigationKidneyKidney DiseasesKidney TransplantationLeadLigandsMediatingModelingMolecularMutationOncogenesPathogenesisPatientsPerivascular FibrosisPlayPopulationPredispositionPrevalenceProcessProductionPublishingRattusRenal HypertensionRenal functionRoleSeriesSmooth MuscleSmooth Muscle MyocytesTelemetryTimeTissuesVascular Smooth MuscleVascular remodelingVeteransVirusarterioleblood pressure elevationcell growthchemokineglomerulosclerosishypertension treatmenthypertensiveimprovedinsightkidney vascular structuremacrophagemembermilitary veterannovelnovel strategiespodocyteresponsesalt sensitivetranscription factortransplant modelvascular inflammation
项目摘要
Hypertensive nephropathy is a common cause of chronic kidney disease (CKD) and is the
second leading cause of end-stage kidney disease (ESKD). The prevalence of CKD is
significantly higher than the general population and demonstrate progressive loss of kidney
function over time, more attention to the underlying mechanisms of hypertensive nephropathy
are required. Remodeling of the afferent arterioles and accompanying glomerulosclerosis are
hallmarks of human hypertensive nephropathy. Despite extensive investigation, there remain
gaps in understanding why some hypertensive patients develop ESKD, while others do not.
The molecular pathogenesis of the arteriolar remodeling in hypertensive nephropathy would
provide clues to this susceptibility, but the multiple variables that associate with the human
condition limit the ability to provide definitive conclusions. Insight into the molecular basis of
renal microvascular remodeling may therefore be gained through the study of relevant animal
models, in particular the Dahl salt-sensitive (SS) rat, a well-characterized model of hypertensive
nephropathy. Our previous studies, which are described in detail in this application, uncovered
an intrinsic defect in the structural/functional relationship of the renal microvasculature of SS
rats occurring with increases in blood pressure. Preliminary and published studies revealed that
hypertension rapidly upregulated expression of both matrix metalloproteinase-9 (MMP-9) and
Chemokine (C-C motif) Ligand 2 (CCL2), a potent pro-inflammatory chemokine, in kidney
microvasculature of SS rats. We further confirmed that ED-1-positive macrophages collected
around the microvessels of hypertensive SS rats. Our combined findings support the working
hypothesis that hypertension-induced kidney disease in SS rats is initiated by glomerular
injury mediated by microvascular smooth muscle production of a milieu that promotes
inflammation, remodeling, and autoregulatory impairment (Fig. 1). We propose 2 aims:
Aim 1: Determine the novel mechanisms of renal microvascular remodeling and autoregulatory
dysfunction in SS rats. Hypothesis: MMP-9 mediates afferent arteriolar remodeling and
impairment of the myogenic response during the development of hypertension.
1.1 Assess renal afferent arteriolar remodeling and autoregulatory behavior and smooth
muscle pathobiology of SSMmp9-/- rats.
1.2 Describe the role of kidney-specific versus systemic expression of MMP-9 in
microvascular remodeling using a kidney transplant model.
Aim 2: Define the mechanisms of the renal microvascular inflammatory process on
hypertensive nephropathy in SS rats. Hypothesis: CCL2 is integrally involved in renal
microvascular remodeling and autoregulatory impairment in hypertensive SS rats.
2.1 Describe the role of CCL2 in microvascular inflammation and autoregulation in
SSCcl2-/- rats.
2.2 Determine the microvascular mechanism of kidney-specific versus systemic
expression of CCL2 in hypertensive nephropathy using a model of kidney
transplantation.
By focusing on the molecular pathogenesis of renal microvascular inflammation and remodeling,
impaired autoregulatory response to hypertension and glomerular injury, these studies will
improve understanding of the molecular basis of CKD and ESKD from hypertension.
高血压肾病是慢性肾脏疾病(CKD)的常见原因,并且是慢性肾脏疾病的主要病因。
终末期肾病(ESKD)的第二大病因。CKD的患病率是
显著高于一般人群,并表现出肾功能进行性丧失
随着时间的推移,更多的关注高血压肾病的潜在机制
are required.传入小动脉的重塑和伴随的肾小球硬化是
人类高血压肾病的标志。尽管进行了广泛的调查,
在理解为什么一些高血压患者发展ESKD,而其他人没有的差距。
高血压肾病小动脉重构的分子发病机制
提供了这种易感性的线索,但与人类相关的多个变量
条件限制了提供明确结论的能力。深入了解的分子基础
因此,可以通过相关动物的研究来获得肾微血管重构
模型,特别是Dahl盐敏感(SS)大鼠,一种良好表征的高血压模型,
肾病我们以前的研究,在本申请中详细描述,
SS肾微血管结构/功能关系的内在缺陷
大鼠血压升高。初步和已发表的研究表明,
高血压迅速上调基质金属蛋白酶-9(MMP-9)和
趋化因子(C-C基序)配体2(CCL 2)是一种强有力的促炎趋化因子,在肾脏中
SS大鼠的微血管。我们进一步证实,收集的艾德-1阳性巨噬细胞
在高血压SS大鼠的微血管周围。我们的综合研究结果支持了
SS大鼠高血压性肾病由肾小球启动假说
由微血管平滑肌产生的环境介导的损伤
炎症、重塑和自身调节受损(图1)。我们提出两个目标:
目的1:确定肾脏微血管重构和自身调节的新机制
SS大鼠的功能障碍。假设:MMP-9介导传入小动脉重塑,
在高血压发展过程中肌原性反应受损。
1.1评估肾传入小动脉重塑和自身调节行为,
SSMmp 9-/-大鼠的肌肉病理学。
1.2描述MMP-9的肾脏特异性表达与系统性表达在
使用肾移植模型进行微血管重塑。
目的2:明确肾微血管炎症过程的机制,
SS大鼠高血压肾病。假设:CCL 2整体参与肾脏
高血压SS大鼠微血管重构和自身调节功能障碍。
2.1描述CCL 2在微血管炎症和自身调节中的作用,
SSCcl 2-/-大鼠。
2.2确定肾脏特异性与全身性的微血管机制
CCL 2在高血压肾病中的表达
移植
通过关注肾微血管炎症和重塑的分子发病机制,
对高血压和肾小球损伤的自动调节反应受损,这些研究将
提高对高血压导致CKD和ESKD的分子基础的认识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL W. SANDERS其他文献
PAUL W. SANDERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL W. SANDERS', 18)}}的其他基金
相似海外基金
Albuminuria and vascular risk in females with chronic kidney disease
女性慢性肾病患者的蛋白尿和血管风险
- 批准号:
481013 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Molecular mechanisms of heparanase-2 (hpa-2) in endothelial cell activation, inflammation and albuminuria
乙酰肝素酶 2 (hpa-2) 在内皮细胞活化、炎症和蛋白尿中的分子机制
- 批准号:
389250244 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Research Grants
Albuminuria and incident chronic lung disease exacerbations in five population-based cohorts
五个基于人群的队列中的蛋白尿和慢性肺病恶化事件
- 批准号:
9144859 - 财政年份:2015
- 资助金额:
-- - 项目类别:
The association between changes in albuminuria and all-cause mortality in patients with type 2 diabetes in the Action in Diabetes and Vascular disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) Study
糖尿病和血管疾病行动:preterAx 和 diamicroN-MR 对照评估 (ADVANCE) 研究中白蛋白尿变化与 2 型糖尿病患者全因死亡率之间的关联
- 批准号:
324375 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Albuminuria and incident chronic lung disease exacerbations in five population-based cohorts
五个基于人群的队列中的蛋白尿和慢性肺病恶化事件
- 批准号:
8997288 - 财政年份:2015
- 资助金额:
-- - 项目类别:
The Role of Nontraditional Glycemic Markers in Diabetes and Albuminuria
非传统血糖标志物在糖尿病和蛋白尿中的作用
- 批准号:
9028606 - 财政年份:2013
- 资助金额:
-- - 项目类别:
The Role of Nontraditional Glycemic Markers in Diabetes and Albuminuria
非传统血糖标志物在糖尿病和蛋白尿中的作用
- 批准号:
8508005 - 财政年份:2013
- 资助金额:
-- - 项目类别:
Investigation of pathogenesis of albuminuria in chronic kidney disease and its association with cardiovascular complications
慢性肾脏病白蛋白尿发病机制及其与心血管并发症的关系研究
- 批准号:
23591209 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
The association of sub-clinical atherosclerosis and estimated glomelular filtration rate with albuminuria among general Japanese.
日本普通人群亚临床动脉粥样硬化和估计肾小球滤过率与蛋白尿的关联。
- 批准号:
23590791 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of mechanism of albuminuria/proteinuria in diabetes in terms of sugar chain
从糖链角度分析糖尿病白蛋白尿/蛋白尿机制
- 批准号:
22790788 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Young Scientists (B)